Patent US4880804A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4880804A Expired / Lapsed US ⏱️ 0.0 years remaining

Angiotensin II receptor blocking benzimidazoles

Assignee: EIDP Inc
•
Filing: 1988-01-07
•
Granted: 1989-11-14
•
Expires: 2008-01-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Substituted benzimidazoles such as <IMAGE> and pharmaceutically suitable salts thereof are useful as angiotensin II blockers. These compounds have activity in treating hypertension and congestive heart failure.

Inventors

  • 👤 David J. Carini
  • 👤 John Jonas V. Duncia
  • 👤 Sung-eun Yoo

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 09:12
CPC Classifications
C; C07; C07D; C07D403/00; C07D403/02; C07D403/12; C07D235/00; C07D235/02; C07D235/04; C07D235/06; C07D235/08; C07D235/16

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 453 words
A compound of the formula ##STR74## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR75## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycoalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR76## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR77## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof; provided that: (1) when R 3 is methyl is must be substituted with --OR 4 or CO 2 R 4 ; (2) when R 3 is --CH═CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH; (6) when R 1 is --CO 2 H, X is not --O--.
Claim 2
Dependent Claim 453 words
A compound of the formula ##STR74## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR75## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycoalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR76## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR77## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof; provided that: (1) when R 3 is methyl is must be substituted with --OR 4 or CO 2 R 4 ; (2) when R 3 is --CH═CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH; (6) when R 1 is --CO 2 H, X is not --O--.
Claim 3
Dependent Claim 108 words
Compound of claim 1 wherein R 1 is --CO 2 H, --NHSO 2 CF 3 ; or ##STR78## R 2 is hydrogen; R 3 is alkyl of 3 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with --OR 4 or CO 2 R 4 ; R 5 is H, alkyl of 1 to 5 carbon atoms, OR 6 or NR 7 R 8 ; R 6 is H, alkyl of 1 to 5 carbon atoms; A is halogen, alkoxy of 1 to 6 carbon atoms; ##STR79## B is H; or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 64 words
Compound of claim 2 wherein R 3 is alkyl of 3 to 5 carbon atoms, alkenyl or akynyl of 3 to 5 carbon atoms each of which may be unsubstituted or substituted with OH, OCH 3 , CO 2 H or CO 2 CH 3 ; ##STR80## n is 1-2; X is a carbon-carbon single bond, or --NHCO--; or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 13 words
Compound of claim 1 which is 2-butyl-1[(2'-carboxybiphenyl-4-yl)methyl]-6-hydroxymethyl-benzimidazole, or a pharmaceutically suitable salt thereof.
Claim 6
Dependent Claim 13 words
Compound of claim 1 which is 2-butyl-1-[(2'-carboxybiphenyl-4-yl)methyl]-5-hydroxymethyl-benzimidazole, or a pharmaceutically suitable salt thereof.
Claim 7
Dependent Claim 13 words
Compound of claim 1 which is 2-butyl-1-[2'-carboxybiphenyl-4-yl)methyl]-6-methoxybenzimidazole, or a pharmaceutically suitable salt thereof.
Claim 8
Dependent Claim 13 words
Compound of claim 1 which is 2-(1-butenyl)-1[(2'-carboxybiphenyl-4-yl)-methyl]-6-hydroxymethylbenzimidazole, or a pharmaceutically suitable salt thereof.
Claim 9
Dependent Claim 13 words
Compound of claim 1 which is 2-butyl-1-[(2'-carboxybiphenyl-4-yl)methyl]-6-chlorobenzimidazole, or a pharmaceutically suitable salt thereof.
Claim 10
Dependent Claim 44 words
Pharmaceutical composition useful for treating hypertension or congestive heart failure in a warm-blooded animal comprising a suitable pharmaceutical carrier and a compound of any one of claims 1 through 8 in an amount effective to lower the animal's blood pressure or relieve the congestion.
Claim 11
Dependent Claim 33 words
Method of treating hypertension in a warm-blooded animal comprising administering to the animal in an amount effective to lower the animal's blood pressure a compound of any one of claims 1 through 8.
Claim 12
Dependent Claim 41 words
Method of treating congestive heart failure in a warm-blooded animal comprising administering to the animal a compound of any one of claims 1 through 8 in an amount effective to correct the hemodynamic burden on the heart to relieve the congestion.
Claim 13
Dependent Claim 465 words
Method of treating hypertension in a warm-blooded animal comprising administering to the animal in an amount effective to lower the animal's blood pressure a compound of the formula: ##STR81## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR82## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR83## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR84## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof; provided that: (1) when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; (2) when R 3 is --CH═CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH.
Claim 14
Dependent Claim 465 words
Method of treating hypertension in a warm-blooded animal comprising administering to the animal in an amount effective to lower the animal's blood pressure a compound of the formula: ##STR81## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR82## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR83## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR84## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof; provided that: (1) when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; (2) when R 3 is --CH═CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH.
Claim 15
Dependent Claim 471 words
Method of treating congestive heart failure in warm-blooded animals comprising administering to the animal a compound of the formula: ##STR85## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR86## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR87## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR88## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof in an amount effective to correct the hemodynamic burden on the heart to relieve the congestion; provided that: (1) when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; (2) when R 3 is --CH=CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH.
Claim 16
Dependent Claim 471 words
Method of treating congestive heart failure in warm-blooded animals comprising administering to the animal a compound of the formula: ##STR85## where R 1 is --CO 2 H, --NHSO 2 CF 3 , ##STR86## R 2 is H, halogen, NO 2 , methoxy, or alkyl of 1 to 4 carbon atoms; R 3 is alkyl of 1 to 6 carbon atoms, alkenyl or alkynyl of 3 to 6 carbon atoms each of which may be unsubstituted or substituted with a halogen atom, --OR 4 or up to two --CO 2 R 4 ; with the proviso that when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; R 4 is H, or alkyl of 1-4 carbon atoms; R 5 is H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, (CH 2 ) m C 6 H 5 , OR 6 , or NR 7 R 8 ; R 6 H, alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl; R 7 and R 8 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl or taken together with nitrogen form a ring of the formula ##STR87## Q is NR 9 , O, or CH 2 ; R 9 is H, alkyl of 1 to 4 carbon atoms, or phenyl; R 10 is alkyl of 1 to 6 carbon atoms; A is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen, alkoxy of 1 to 6 carbon atoms; ##STR88## B is H, alkyl of 1 to 10 carbon atoms, C r F 2r+1 where r=1-6, C 6 F 5 , halogen or alkoxy of 1 to 6 carbon atoms; X is a carbon-carbon single bond, --CO--, --O--, --NHCO--, or --OCH 2 --; n is 1 to 6; m is 0 to 3; p is 0 or 1; or a pharmaceutically acceptable salt thereof in an amount effective to correct the hemodynamic burden on the heart to relieve the congestion; provided that: (1) when R 3 is methyl it must be substituted with --OR 4 or --CO 2 R 4 ; (2) when R 3 is --CH=CH--CO 2 Et, then X is not --NHCO; (3) when R 3 is CH 2 OH, CH=CHCO 2 H or CH 2 CH 2 CO 2 H and A and B are hydrogen, then X cannot be a carbon-carbon single bond; (4) when R 1 is --CO 2 H, R 3 is butyl, and X is a carbon-carbon single bond, then A is not 5-Cl; (5) when R 1 is --CO 2 H, R 3 is CH 2 OCH 3 and X is a carbon-carbon single bond, then A is not 5-CH 2 OH.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-11-13 1993-05-15 1993-11-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-11-13 1997-05-15 1997-11-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-11-13 2001-05-15 2001-11-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag